FDA Clears Withings' Smart Watch For Detecting AF and Measuring Blood Oxygen
Executive Summary
The French company is promoting its ScanWatch as the first wearable device to receive FDA clearance for both atrial fibrillation detection through medical grade ECG and measuring SpO2 levels from the wrist.
You may also be interested in...
Minute Insight: Withings Continues Push Into Wearables With Two Acquisitions
The consumer device company recently bought 8Fit, a German fitness app developer, and Impeto Medical, the developer of the Sudoscan technology for detecting and tracking small fiber neuropathy.
Digital Health Roundup: Digital Therapeutics Push Ahead On Standards, Coverage; FDA’s Software Guidance
In this roundup feature focusing on developments in digital health, we highlight the key news and announcements from October.
New Global Alliance To Drive Momentum On Decentralized Trials
A new multi-stakeholder alliance wants to improve the adoption of decentralized clinical trials that have already drawn much attention during the COVID-19 pandemic. There are plans to aggregate best practices, share evidence and information, and identify and address key barriers.